Related Experiment Videos
Anticonvulsant action of topiramate against motor seizures in developing rats
R Haugvicová1, H Kubová, M Skutová
1Institute of Physiology, Academy of Sciences of the Czech Republic, Prague.
Insights
Topiramate (TPM) effectively suppresses generalized tonic-clonic seizures in developing rats across all studied ages. Its anticonvulsant action is more prolonged in older rats, suggesting developmental differences in drug mechanisms.
Area of Science:
- Neuroscience
- Pharmacology
- Developmental Biology
Background:
- Epilepsy is a common neurological disorder with significant impact on developing brains.
- Understanding the efficacy and mechanisms of anticonvulsant drugs during development is crucial for effective treatment.
- Topiramate (TPM) is a broad-spectrum anticonvulsant used in epilepsy treatment.
Purpose of the Study:
- To investigate the anticonvulsant effects of topiramate (TPM) in rats at different developmental stages.
- To evaluate the dose-dependent and time-course of TPM's action on seizure activity in young rats.
Main Methods:
- Motor seizures were induced using pentylenetetrazol in Wistar rats aged 7, 12, 18, 25, and 90 days.
- Topiramate (TPM) was administered intraperitoneally at various doses prior to pentylenetetrazol challenge.
- Seizure incidence, pattern, and duration of TPM's effect were assessed across different age groups.
Main Results:
- TPM did not affect minimal seizures but reliably suppressed the tonic phase of generalized tonic-clonic seizures in all age groups.
- A decrease in generalized seizure incidence was observed in 7-day-old rats at specific TPM doses.
- The suppression of the tonic phase lasted longer in 25-day-old rats (over 6 hours) compared to 12-day-old rats (up to 12 hours).
Conclusions:
- Topiramate (TPM) demonstrates consistent anticonvulsant activity against the tonic phase of generalized seizures throughout rat development.
- TPM exhibits a more comprehensive seizure suppression in very young (7-day-old) rats.
- The differential duration of action suggests distinct mechanisms underlying TPM's anticonvulsant effects during different developmental periods.
Purpose:
To study the anticonvulsant action of topiramate (TPM) in developing rats.
Methods:
Motor seizures were elicited by administering pentylenetetrazol (100 mg/kg subcutaneously) in five age groups of Wistar rats (7, 12, 18, 25, and 90 days old). TPM was administered intraperitoneally in doses from 10 to 640 mg/kg 2 hours before pentylenetetrazol. The time course of TPM action was studied in 12- and 25-day-old rats up to 24 hours after the 160-mg/kg dose, and the incidence and pattern of seizures were evaluated.
Results:
TPM did not influence minimal seizures (clonus of forelimb and head muscles with preserved righting ability). Generalized tonic-clonic seizures, however, were reliably changed at all developmental stages studied. The tonic phase was suppressed so that the majority of animals exhibited generalized clonic seizures (with a loss of righting reflexes). In addition, the incidence of generalized seizures was decreased after the 20-, 40-, and 80-mg/kg doses in the 7-day-old rat pups. The specific suppression of the tonic phase of generalized seizures was observed up to 12 hours in the 12-day-old rat pups. The same result was obtained over 6 hours after TPM administration in the 25-day-old animals, and with longer intervals the incidence of generalized seizures decreased in this age group.
Conclusions:
TPM exhibits stable anticonvulsant action against the tonic phase of generalized tonic-clonic seizures throughout development. In addition, it suppresses all phases of generalized seizures in 7-day-old rats. The anticonvulsant action of TPM lasted longer in 25-day-old than in 12-day-old rats. The two actions of TPM might be ascribed to two different mechanisms of action.